Versant Voyageurs I, L.P., 10% Owner at Black Diamond Therapeutics, Inc. (BDTX), sold 21,372 shares at $33.14 ($708K) on 2020-11-04, disclosed to the SEC on 2020-11-06.
Scheduled sale ($708k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.14 | 292 | $10K | 1.4% |
| 2 | $33.14 | 2,208 | $73K | 10.3% |
| 3 | $33.14 | 2,208 | $73K | 10.3% |
| 4 | $33.15 | 1,032 | $34K | 4.8% |
| 5 | $33.15 | 7,816 | $259K | 36.6% |
| 6 | $33.15 | 7,816 |
| $259K |
| 36.6% |
| Total | $33.15 avg | 21,372 | $708K | 100% |
| Filing → |